Marta Teixeira Pinto is responsible for the “in vivo CAM assays unit” at Ipatimup/I3S. This core facility provides scientific expertise and services using the chick embryo model specifically, its chorioallantoic membrane (CAM). The research facility provides access to alternative/additional in vivo tools to evaluate angiogenesis, tumorigenesis, invasion, metastization and vascular permeability. The available collection of functional assays can be applied to cells, biomaterials, drugs, supernatants or extracts.
MT Pinto joined Ipatimup as an Investigator Ciência 2008 (2009) of the Cancer Genetics Group and was mainly dedicated to the study of cancer related features using the CAM model. After setting up the lab and implementing several CAM assays, she established the “In vivo CAM assays service” at Ipatimup (2012) and founded the spin-off “Expertus, CAM assays” (2013-2015). MT Pinto graduated in Biochemistry (FCUP; 1999) and both MSc (FMUL; 2001) and PhD (FMUP; 2008) theses concerned the study of the endogenous pain control system in acute and chronic pain states and involved extensive use of animal models. MT Pinto has published 26 papers in international peer reviewed journals (Q1) with an H index of 12 (ResearcherID: J-2519-2013). She is co-author of two patents.